drug prices drug prices

Many Medicare patients don't realize they can sometimes pay less out of pocket for a prescription drug if they pay cash, instead of the insurance copay. Scott Olson/Getty Images hide caption

toggle caption
Scott Olson/Getty Images

Health and Human Services Secretary Alex Azar talked Friday about the administration's plans to lower drug prices as President Trump looked on in the White House Rose Garden. Chip Somodevilla/Getty Images hide caption

toggle caption
Chip Somodevilla/Getty Images

With drug prices in the election spotlight, the pharmaceutical industry's main trade group raised its revenue and spending. PeopleImages/Getty Images hide caption

toggle caption
PeopleImages/Getty Images

When Ohio voters head to the polls Tuesday, they'll be able to weigh in on a ballot measure that aims to get better drug prices for state programs. Jay LaPrete/Getty Images hide caption

toggle caption
Jay LaPrete/Getty Images

Speaker of the House Paul Ryan, center, and other lawmakers have a plan to overhaul the tax code that includes a provision that would repeal a tax credit for makers of drugs for rare diseases. Alex Wong/Getty Images hide caption

toggle caption
Alex Wong/Getty Images

FDA Commissioner Scott Gottlieb says the agency will close a loophole that lets drug manufacturers skip pediatric testing in some drugs intended for children. Zach Gibson/Getty Images hide caption

toggle caption
Zach Gibson/Getty Images

First responders in Washington, D.C., bring naloxone on every emergency call. Shelby Knowles/NPR hide caption

toggle caption
Shelby Knowles/NPR

First Responders Spending More On Overdose Reversal Drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/541626627/542286101" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Juanita Milton, who suffers from COPD, uses her nebulizer with albuterol sulfate at her home in Live Oak, Texas. Carolyn Van Houten for Kaiser Health News hide caption

toggle caption
Carolyn Van Houten for Kaiser Health News

Many COPD Patients Struggle To Pay For Each Breath

  • Download
  • <iframe src="https://www.npr.org/player/embed/529759280/531269129" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An organization campaigning against foreign drug imports has deep connections to the lobbying group PhRMA, which includes Eli Lilly, Pfizer and Bayer. Bill Diodato/Getty Images hide caption

toggle caption
Bill Diodato/Getty Images

Cancer patient John Krahne has delayed taking a prescribed cancer drug because it was too expensive. He walks near his home in Santa Rosa, Calif. Robert Durell for Kaiser Health News hide caption

toggle caption
Robert Durell for Kaiser Health News

Sen. Tom Cotton, R-Ark., is one of three GOP senators seeking an investigation into six-figure annual costs for drugs intended to treat rare diseases. Alex Brandon/AP hide caption

toggle caption
Alex Brandon/AP

State lawmakers in West Virginia say their budget choices are only getting tougher. About a third of state residents are on Medicaid. OZinOH/Flickr hide caption

toggle caption
OZinOH/Flickr

West Virginia Grapples With High Drug Costs

  • Download
  • <iframe src="https://www.npr.org/player/embed/496762064/498091468" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Heather Bresch, CEO of Mylan Pharmacueticals, will face lawmakers' questions Wednesday about the company's steep price hikes for the company's life-saving EpiPen auto-injector. Dale Sparks/AP hide caption

toggle caption
Dale Sparks/AP

Mylan CEO Claims EpiPens Aren't As Profitable As Everyone Thinks

  • Download
  • <iframe src="https://www.npr.org/player/embed/494879607/494914776" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript